<DOC>
	<DOC>NCT00954980</DOC>
	<brief_summary>The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.</brief_summary>
	<brief_title>Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins</brief_title>
	<detailed_description>A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years. There are no deviations in usual clinical assessment and care of patients seeking varicose vein treatment. The purpose of this protocol is only to collect clinical and biomarker information related to this standard treatment.</detailed_description>
	<mesh_term>Varicose Veins</mesh_term>
	<criteria>Clinical diagnosis of varicose veins</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Varicose Veins</keyword>
	<keyword>Superficial Thrombophlebitis</keyword>
	<keyword>Deep Vein Thrombosis</keyword>
	<keyword>Ulceration</keyword>
	<keyword>leg pain</keyword>
	<keyword>leg swelling</keyword>
</DOC>